The story of Viagra presents a complex case study for pharmaceutical stakeholders. Initially a runaway success, producing billions in profits, the right lapse has revealed the problems of relying on a one-off product. While generic versions have considerably eroded share, questions remain about the overall outlook of companies heavily invested in r

The neon lights of Las Vegas have always been synonymous with risk, but lately, a new kind of gamble has taken center stage: copyright. With Bitcoin and Ethereum prices soaring to dizzying heights, a wave of speculators are flocking to the desert metropolis, hoping to get lucky. Fueling this frenzy is an unlikely alliance between the world-famous c